Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
meningococcal polysaccharide a + c
- Development stage
- Unknown
- Lead developer
- Wacker Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
Meningococcal polysaccharide a + c is an inactivated bacterial vaccine composed of purified capsular polysaccharides from *Neisseria meningitidis* serogroups A and C. It is used for active immunization to prevent invasive diseases such as meningitis and septicemia caused by these specific serogroups. The mechanism of action involves stimulating the immune system to produce bactericidal antibodies against the capsular antigens of *N. meningitidis* groups A and C, thereby providing protection against infection[5]. This type of vaccine does not contain live bacteria and cannot cause disease[3]. It has been used in outbreak control, travel medicine, military populations, and regions with high incidence rates.
- Brand names
- Menomune
- Other names
- meningococcal polysaccharide vaccine groups a and cgroup A and C meningococcal polysaccharide vaccine
02
Targets
NmA CPS (Neisseria meningitidis group A capsular polysaccharide)Neisseria meningitidis group C capsular polysaccharide
Beyond the preview
Go deeper on meningococcal polysaccharide a + c.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on meningococcal polysaccharide a + c.